HHS-FDA-22-0117 Archives - American Oversight
Skip to main content
American Oversight
An informed public,
a strengthened democracy.
Donate
Subscribe
Investigations
All Investigations
Voting Rights
Threats to Democracy
Trump Accountability
Abuse of Power
Congressional Investigations
Coronavirus Response
Ethics & Conflicts
Influence & Access
Misconduct
Policy & Regulations
Political Appointees
Corporate Complicity
States
Arizona
Florida
Georgia
Pennsylvania
Texas
Wisconsin
See All States
Documents
News
En Español
Search
Search
Search
FOIA Number: HHS-FDA-22-0117
FOIA to FDA for Analyses or Assessments Used by FDA During Deliberations Over Aduhelm
February 2, 2022
FOIA request to the U.S. Food and Drug Administration seeking any final analyses or assessments used by FDA during deliberations over the approval of Aduhelm (aducanumab), an Alzheimer's drug produced by Biogen.
Read more
Pagination